HeartBeat.bio (HBB) is an emerging TechBio company developing a next-generation drug discovery platform for heart diseases. Our so-called Cardioid Drug Discovery Platform is based on a proprietary iPSC-derived single and multi-chamber cardiac organoid model. We combine this unique human biology with state-of-the-art hardware solutions to industrialize the organoid cultivation and screening process as well as AI-supported software for high-content and big data analysis. HBB pursues an end-to-end human-centric drug discovery approach along the entire pre-clinical value chain: Starting with target identification and validation, disease modeling, hit identification and confirmation, leading up to compound development and profiling as well as dose finding and clinical trials-in-a-dish applications for patient segmentation and clinical trial design. With this human-data driven approach, we expect to overcome the current bottlenecks in preclinical drug discovery and thus develop drugs faster, more cost-effectively and with a higher probability of success. HBB is focused on Heart Failure which is a severe condition with a high medical need and a significant lack of innovation affecting more than 30 million people in the major pharmaceutical markets. We plan to build a broad portfolio of self-funded and partnered pre-clinical assets within a reasonable time frame of 3-5 years. Initially, the HBB drug discovery program is centered on various types of drug-induced and genetic cardiomyopathies. Programs for post-myocardial infarction therapy, cardiac remodeling and regeneration will follow along with ongoing business development activities.
Externer Link zu HeartBeat.bio AG
Dr. Bohr-Gasse 7
Vienna Biocenter 6
Vienna, 1030 , AT
HeartBeat.bio AG hat dies direkt geteilt
Let's celebrate what we do best: partnerships. Join me at BIO-Europe, November 4–6, 2024, in Stockholm, Sweden, where the event marks 30 years of facilitating partnerships. Looking forward to welcome you. Register here: https://lnkd.in/ezDGX2sf Informa Connect
Thank you to Zefyron for mentioning HeartBeat.bio AG in their list of Austrian Biotech Innovators reshaping the future of drug discovery and healthcare. 😀
📈💡Austrian Biotech Innovators With Austria’s biotech ecosystem continually evolving, its contribution to global healthcare is set to grow exponentially. From breakthrough therapies to cutting-edge diagnostics, early-stage startups are pushing the boundaries of what’s possible. Backed by a robust ecosystem of academia, government, and industry collaboration, these innovators are setting the stage for the next big leap in healthcare. But it’s not just about invention—it’s about impact. These startups are tackling some of the world’s most pressing health challenges, striving to cut costs, improve patient outcomes, and expand treatment access on a global scale. 🔗 Read more about the Top 10 Early-Stage Life Sciences/Biotech Startups reshaping the future: https://lnkd.in/gF4pibuy ✨ Featured Startups: ◾ Sarcura – Daniela Buchmayr, Erwin Gorjup (Cell therapy manufacturing) ◾ HeartBeat.bio AG – Michael Krebs, Florian Fuchs (Cardiac drug discovery) ◾ a:head bio AG – Oliver Szolar, Madeline Lancaster (CNS drug discovery) ◾ VALANX Biotech – Michael Lukesch (Protein conjugation) ◾ Cellectric Biosciences – Terje Wimberger, Klemens Wassermann(Precision diagnostics) ◾ Biolyz – Marlon Millard (Non-invasive analytics) ◾ Solgate – Ariel Bensimon, Giulio Superti-Furga, Stefan Kubicek, and Georg Winter (Metabolic disease targeting) ◾ HD Immune – Stefan Bartl, Lionel Wightman (Huntington’s treatment) ◾ Phoenestra GmbH – Klaus Graumann(Cell therapy bioprocessing) ◾ Luminous Labs – Barbara Sekulovska, Thomas Lechner (Red light therapy) ✨ Key Investors Supporting BioTech Innovation: XYZ Ventures | xista science ventures | Nina Capital |CTI Life Sciences Fund | Tensor Ventures | Atrinum. Ventures AG | Austria Wirtschaftsservice | Austrian Angel Investor Association (aaia) 🔍 Explore more such startups on Zefyron's Startup and Investor Database : bit.ly/Zefyron 🆓 Sign up for FREE: bit.ly/ZefyronFree #BiotechInnovation #LifeSciences #Healthcare #AustrianStartups
HeartBeat.bio AG hat dies direkt geteilt
🌟We’re thrilled to kick off the Advanced Imaging and Organoid Technologies Meeting with an insightful keynote from Florian Fuchs of HeartBeat.bio AG. His talk, ‘Unleashing the Potential of 3D Biology in Automated High-Throughput Cardioids for Drug Discovery and Toxicity Testing,’ delves into the cutting-edge advancements in 3D biology. These innovations are set to revolutionize drug discovery and testing, enabling faster, more accurate results. Stay tuned for more groundbreaking discussions as we explore the future of science and innovation! #ImgUserMeetingMD24 #Imaging #3dbiology #drugdiscovery #drugdevelopment
If you are attending the Heart Days of the German Society of Cardiology in Hamburg today, be sure not to miss today's presentation by HeartBeat.bio AG. The presentation starts at 1:50 p.m. in the Plaza Room as part of the eCardiology session chaired by Benjamin Meder. https://lnkd.in/e2dVAWRZ
3.564 Follower:innen
🔊 DGK Herztage 2024 in Hamburg: Jetzt anmelden! Vom 26. bis 28. September 2024 erwartet Sie im Congress Center Hamburg ein ausführliches Kardiologie-Update mit 118 Sitzungen und fünf Kongressen unter einem Dach: ✅ Kardiologie Aktuell ✅ Deutsche Rhythmus Tage ✅ AGIK Live ✅ DGK-Akademie ✅ Basic Science Meeting Neu in diesem Jahr: Ein interaktiver Plaza-Bereich, der den interdisziplinären und kollegialen Austausch fördert und spannende Diskussionen ermöglicht. 🔗 Jetzt registrieren und dabei sein: https://lnkd.in/ewBnxjgW #DGK #DGKHerztage #DGK2024HT #Kardiologie #Herzgesundheit
Another great example of the power of human organoids in drug research and development and their increasing application in the pharmaceutical industry. Thanks to Kimberly Homan and Genentech for sharing their experience with us. It's definitely worth listening to! #stemcell #stemcells #organoids #drugdiscovery #drugscreening #drugsafety #toxicology #drugdevelopment #highthroughput
Kim Homan, who leads our complex in vitro systems group, is at the forefront of organoid research by modeling organs in a dish. Listen to the latest episode of our podcast, Two Scientists Walk Into a Bar, where Kim explains how she uses organoids to more accurately predict health outcomes and increase representation in clinical trials. http://spr.ly/6044oWwq2
Thank you to LISAvienna for organizing the SLAS (Society for Laboratory Automation and Screening) Austrian Community Meet-up and congratulations for bringing the SLAS Europe Conference & Exhibition to Vienna in 2026. 👍🥳
Our Cluster Manger Elvira Kainersdorfer attended the SLAS Austrian Community Meet-Up at Future Health Lab yesterday and enjoyed networking. Thank you Mary Geismann (SLAS Director Membership & Engagement) and Manuela Beil-Peter (SLAS European Ambassador) for your insights on SLAS (Society for Laboratory Automation and Screening)'s goals and its working groups. https://www.slas.org/ In addition, it’s been a pleasure learning more about all the offers for compound storage at Specs, part of eMolecules, Inc. | eMolecules, from Tamara Baptist, Sales Manager. https://lnkd.in/eVVfWchC Save the date for the next SLAS Europe Conference & Exhibition: May 20-22, 2025, in Hamburg https://lnkd.in/gf5U8dht AND: Mark your calendar for May 19-21, 2026, when the conference will be held at Messe Wien Exhibition & Congress Center in #Vienna! 😎 https://lnkd.in/gN_9jBe2 Lokesh Pimpale | Hannah Keresztes Thomas Moser Manfred Taschner | Melvin Jose | Robert Hanes | Oslo University Hospital | HeartBeat.bio AG | Myllia Biotechnology | LifeTaq-Analytics GmbH | Cell Signaling Technology (CST) | Vienna Convention Bureau
Many thanks to Startup Stash for honoring HeartBeat.bio AG as one of the Top 10 Austrian Startups to Watch in 2024. #startups #venturecapital #organoids #drugdiscovery #drugscreening #drugdevelopment #cardiac #cardiology #cardiovasculardisease #heartfailure #heartdisease
HeartBeat.bio AG, an Austrian startup, is revolutionizing cardiovascular drug discovery with its 3D human tissue platform. Their AI-powered approach is making waves & could be the key to successful heart disease treatments! #HealthTech #DrugDiscovery #MedTech
HeartBeat.bio AG hat dies direkt geteilt
📢 Speaker Update! Florian Fuchs from HeartBeat.bio AG will be sharing groundbreaking insights into cardiac organoid technology for drug discovery and safety testing at our upcoming event. Don't miss this chance to learn how HeartBeat.bio is advancing cardiac research and transforming drug development! 🌟 📅 1st of October | Free Admission Limited spots available—reserve your spot now! #Organoids #DrugDiscovery #Cardiotoxicity #HeartResearch #Innovation #Networking
This year's Heart Days of the German Cardiac Society will take place from September 26 to 28 at the Congress Center in Hamburg. Our CSO Dr. Pablo Hofbauer and Senior Scientist Dr. Ruben van Helden, will present HeartBeat.bio AG's unique Cardioid-based and AI-assisted cardiac drug discovery platform on Thursday, September 26, 2024. We look forward to many meetings and discussions with scientists and clinicians interested in collaborative drug discovery projects related to cardiomyopathies, myocardial infarction, and cardio-protection/remodeling/regeneration. Interested participants are welcome to contact us at [email protected] to arrange on-site meetups. #3Dmodels #organoids #cardiology #cardiomyopathies #cardiacdiseases #cardiovasculardiseases #myocardialinfarction #cardiacremodeling #cardiacregeneration #cardioprotection #drugdiscovery
3.564 Follower:innen
🔊 DGK Herztage 2024 in Hamburg: Jetzt anmelden! Vom 26. bis 28. September 2024 erwartet Sie im Congress Center Hamburg ein ausführliches Kardiologie-Update mit 118 Sitzungen und fünf Kongressen unter einem Dach: ✅ Kardiologie Aktuell ✅ Deutsche Rhythmus Tage ✅ AGIK Live ✅ DGK-Akademie ✅ Basic Science Meeting Neu in diesem Jahr: Ein interaktiver Plaza-Bereich, der den interdisziplinären und kollegialen Austausch fördert und spannende Diskussionen ermöglicht. 🔗 Jetzt registrieren und dabei sein: https://lnkd.in/ewBnxjgW #DGK #DGKHerztage #DGK2024HT #Kardiologie #Herzgesundheit